Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Mechanistic Studies of Drug-Disease and Drug-Drug Interactions. Edition No. 1

VDM Publishing House, Aug 2009, Pages: 140


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Every minute, we are exposed to and involuntarily absorb xenobiotics which may produce beneficial outcomes or harmful effects on our bodies. Drug metabolism is initially a defensive mechanism driven by certain enzymes to facilitate excretion and in turn reduce the body burden of the absorbed xenobiotics. However, the capacity of this protective system is regulated by factors including disease states, absorbed xenobiotics and genetic factors. Cytochrome P450 3A4 (CYP3A4) is the most abundant phase I drug metabolism enzyme in human liver and its expression levels affect the capacity of drug metabolism. In this book, mechanisms have been investigated on regulation of CYP3A4 gene expression through modulating pregnane X receptor transcriptional activity under inflammation and by xenobiotics. This book also introduces basic knowledge of xenobiotics and their disposition, drug metabolizing systems, nuclear receptors as xenosensors, as well as inflammation and NF-?B. The information provided is useful to professionals and students in the fields of pharmaceuticals, pharmacy, medicinal therapeutics, chemical risk assessment and related scientific research.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds